SCHEMBL24848632

SCHEMBL24848632

CC(C)c1nsc2cc(F)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GCGR P47871 7/20 0.35
CCNB2 O95067 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
MPI P34949 4/20 0.33
KAT2B Q92831 1/20 0.33
AXL P30530 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12589415 0.80 LMNA (0.33) ALDH1A1LMNAMAPTKDM4E
SCHEMBL20048894 0.80 NPC1 (0.41) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL20047646 0.76 KIF11 (0.37) ALDH1A1MAPTMEN1KMT2ACDK1
SCHEMBL23084276 0.76 NPC1 (0.38) ALDH1A1LMNAMAPTKDM4EHTT
SCHEMBL1121782 0.76 CCNB2 (0.44) ALDH1A1LMNAMAPTPOLBCCNB2
SCHEMBL20048892 0.74 EIF4A3 (0.33)
SCHEMBL4546569 0.73 KDM4E (0.50) ALDH1A1LMNAMAPTKDM4EEPAS1
SCHEMBL8124099 0.72 BCKDK (0.45) ALDH1A1LMNAMAPTPOLBMEN1
SCHEMBL30487367 0.72 ALDH1A1 (0.53) ALDH1A1LMNAMAPTPOLBMEN1
SCHEMBL12589428 0.69 LMNA (0.33) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002364-A1 BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002364-A1 BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF GPER1, GABRQ, GPR39 ALDH1A1 3177/4885LMNA 4444/4885MAPT 876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.